Biotrak Research And Diagnostics Centre Profile
Key Indicators
- Authorised Capital ₹ 1.45 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.50 M
as on 17-12-2024
- Revenue 351.24%
(FY 2022)
- Profit 356.81%
(FY 2022)
- Ebitda -278.11%
(FY 2022)
- Net Worth 35.33%
(FY 2022)
- Total Assets 60.64%
(FY 2022)
About Biotrak Research And Diagnostics Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.45 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Madhuri Nandwani and Trupti Morade serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC280557
- Company No.
280557
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Biotrak Research And Diagnostics Centre?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madhuri Nandwani | Director | 29-Nov-2022 | Current |
Trupti Morade | Director | 29-Nov-2022 | Current |
Financial Performance of Biotrak Research And Diagnostics Centre.
Biotrak Research And Diagnostics Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 351.24% increase. The company also saw a substantial improvement in profitability, with a 356.81% increase in profit. The company's net worth Soared by an impressive increase of 35.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Biotrak Research And Diagnostics Centre?
In 2019, Biotrak Research And Diagnostics Centre had a promoter holding of 66.66% and a public holding of 33.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Fintax Buildcom Advisory Private LimitedActive 8 years 9 months
Madhuri Nandwani and Trupti Morade are mutual person
- Aprify Advisory Private LimitedActive 8 years 7 months
Madhuri Nandwani and Trupti Morade are mutual person
- Encon Engineering Construction Services Private LimitedActive 20 years 9 months
Trupti Morade is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
The Jalgaon Peoples Co-Op Bank Limited Creation Date: 08 Mar 2018 | ₹3.00 M | Satisfied |
Others Creation Date: 21 Sep 2017 | ₹2.07 M | Satisfied |
Others Creation Date: 31 Mar 2017 | ₹2.43 M | Satisfied |
How Many Employees Work at Biotrak Research And Diagnostics Centre?
Unlock and access historical data on people associated with Biotrak Research And Diagnostics Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotrak Research And Diagnostics Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotrak Research And Diagnostics Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.